Company Filing History:
Years Active: 2020-2022
Title: Wencui Ma: Innovator in Antibody Development
Introduction
Wencui Ma is a notable inventor based in Taicang, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. With a total of two patents to his name, Ma's work focuses on innovative solutions for treating diseases.
Latest Patents
Wencui Ma's latest patents include the development of anti-CD4 antibodies. This patent provides anti-CD4 antibodies or antigen-binding fragments, isolated polynucleotides encoding the same, pharmaceutical compositions, and their uses. Another significant patent is for anti-CTLA4 antibodies, which block the binding of CTLA4 to its ligand. These antibodies are crucial for developing agents that can treat diseases such as cancer.
Career Highlights
Throughout his career, Wencui Ma has worked with Crown Bioscience Inc. and Crown Bioscience, Inc. (Taicang). His experience in these companies has allowed him to advance his research and contribute to the field of antibody development.
Collaborations
Wencui Ma has collaborated with notable individuals in his field, including Ziyong Sun and Hongli Ma. These collaborations have further enriched his research and innovation efforts.
Conclusion
Wencui Ma is a prominent inventor whose work in antibody development has the potential to impact the treatment of various diseases. His patents reflect his commitment to advancing medical science and improving patient outcomes.